VAERS reports by lot

GSK Hepatitis A lot EK59B: VAERS reports

38 VAERS reports list lot EK59B as a GSK Hepatitis A vaccine, received between 2019-11-19 and 2022-07-12. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
38
Reports
0%
Marked serious
0
With a death outcome
18
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Neurological822%
Gastrointestinal617%
Injection-site / Local reaction617%
Allergic / Anaphylactic514%
Musculoskeletal411%
Dermatological (non-injection-site)38%
General / Systemic (non-local)26%
Cardiac / Cardiovascular13%
Autoimmune / Immune-mediated13%

Where reports came from

U.S. state of the reporter, where given (top 12).

Washington5
North Carolina5
Missouri3
Texas3
Florida2
New York2
Pennsylvania2
Maryland2
Georgia2
Indiana2
Kentucky1
Illinois1

Reports by month received

2019-111
2019-121
2020-011
2020-022
2020-033
2020-053
2020-061
2020-111
2021-041
2021-052
2021-074
2021-081
2021-094
2021-111
2022-036
2022-042
2022-053
2022-071

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.